EVOSMALL

Evotec SE

HealthcareDrug Manufacturers - Specialty & Generic
$3.24
$0.00(+3.02%)
52W$2.31
$4.80
Updated May 7, 12:00 AM
RSI58
RS Rating30/99
Beta1.08
Volatility58%
F-Score4/9
Mkt Cap$1.2B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Evotec SE is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 30), showing significant lag compared to the market leaders. Earnings growth of 137% provides fundamental context to the price action. Investors should exercise caution due to high volatility (58% annualized), which requires wider risk management.

Relative Strength
30
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
1.08
vs S&P 500
MARKET
52W Position
37%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$2.86
50 SMA > 100 SMA$3.14
100 SMA > 150 SMA$3.27
150 SMA > 200 SMA$3.38

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$3.08+5.09%ABOVE
50 SMA$2.86+13.43%ABOVE
100 SMA$3.14+3.22%ABOVE
150 SMA$3.27-1.00%BELOW
200 SMA$3.38-4.12%BELOW

Price Performance

1D+3.0%
1W+10.2%
1M+23.7%
3M-8.2%
6M-2.1%
YTD+1.9%
1Y-20.0%
3Y-28.7%
52-Week Trading Range37% from low
$3.24
52W Low$2.31
52W High$4.80

Technical Indicators

RSI (14)NEUTRAL
57.5
305070
VCP ScoreCOOL
3/10
Base depth: 42.1%

Risk Profile

Beta
1.08
52W Vol
58%
ATR
$0.15
Max DD (1Y)
-51%

Volume Analysis

Today
138.9K
50D Avg
120.0K
Vol Ratio
1.16x
Liquidity
ILLIQUID

Earnings Momentum

Q1'25-50%
$-0.09
Q2'25+56%
$-0.12
Q3'25-9%
$-0.12
Q4'25+137%
$0.04
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+19.48%
5 Years:+8.62%
3 Years:+0.26%
TTM:-1.38%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+47.42%

Stock Price CAGR

10 Years:+5.00%
5 Years:-31.05%
3 Years:-28.73%
1 Year:-20.00%

Return on Equity

10Y Avg:2.2%
5Y Avg:-6.4%
3Y Avg:-12.5%
Last Year:-11.5%

Key Metrics

Market Cap$1.2B
Gross Margin8.3%
Net Margin-13.1%
Piotroski F-Score4/9

Frequently Asked Questions

Is EVO in an uptrend right now?

EVO has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is EVO overbought or oversold?

EVO's RSI (14) is 58. The stock is in neutral territory, neither overbought nor oversold.

Is EVO outperforming the market?

EVO has a Relative Strength (RS) Rating of 30 out of 99. EVO is currently lagging the broader market.

Where is EVO in its 52-week range?

EVO is trading at $3.24, which is 68% of its 52-week high ($4.80) and 37% above its 52-week low ($2.31).

How volatile is EVO?

EVO has a Beta of 1.08 and 52-week volatility of 58%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.